12/18
04:10 pm
evh
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Medium
Report
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
12/3
08:29 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.
Medium
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.
11/22
10:40 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.
11/19
09:14 am
evh
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
Low
Report
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
11/18
09:27 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.
11/13
01:46 pm
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Citigroup Inc. from $33.00 to $21.00. They now have a "buy" rating on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Citigroup Inc. from $33.00 to $21.00. They now have a "buy" rating on the stock.
11/12
10:45 am
evh
Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $20.00 price target on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $20.00 price target on the stock.
11/11
09:25 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Barclays PLC from $39.00 to $19.00. They now have an "overweight" rating on the stock.
Medium
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Barclays PLC from $39.00 to $19.00. They now have an "overweight" rating on the stock.
11/8
04:56 pm
evh
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
High
Report
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
11/8
11:17 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $45.00 to $34.00. They now have an "outperform" rating on the stock.
Medium
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $45.00 to $34.00. They now have an "outperform" rating on the stock.
11/8
02:48 am
evh
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... [Yahoo! Finance]
High
Report
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... [Yahoo! Finance]
11/8
01:09 am
evh
Evolent Health (EVH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
High
Report
Evolent Health (EVH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/7
04:17 pm
evh
Evolent Announces Third Quarter 2024 Results [Yahoo! Finance]
High
Report
Evolent Announces Third Quarter 2024 Results [Yahoo! Finance]
11/7
04:15 pm
evh
Humana and Evolent Expand Partnership to Enhance Oncology Care
High
Report
Humana and Evolent Expand Partnership to Enhance Oncology Care
11/7
04:10 pm
evh
Evolent Announces Third Quarter 2024 Results
High
Report
Evolent Announces Third Quarter 2024 Results
11/6
11:24 am
evh
Unlocking Q3 Potential of Evolent Health (EVH): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Unlocking Q3 Potential of Evolent Health (EVH): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]
11/6
07:21 am
evh
Evolent Health Inc (EVH) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Evolent Health Inc (EVH) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
11/5
02:02 pm
evh
Why Evolent Health (EVH) is Poised to Beat Earnings Estimates Again [Yahoo! Finance]
Low
Report
Why Evolent Health (EVH) is Poised to Beat Earnings Estimates Again [Yahoo! Finance]
11/5
12:13 pm
evh
KANZHUN LIMITED Sponsored ADR (BZ) to Report Q3 Results: What Awaits? [Yahoo! Finance]
Low
Report
KANZHUN LIMITED Sponsored ADR (BZ) to Report Q3 Results: What Awaits? [Yahoo! Finance]
10/29
06:19 pm
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Citigroup Inc. from $35.00 to $33.00. They now have a "buy" rating on the stock.
Medium
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Citigroup Inc. from $35.00 to $33.00. They now have a "buy" rating on the stock.
10/22
09:00 am
evh
Define Ventures Appoints Bruce Broussard as Venture Partner
Medium
Report
Define Ventures Appoints Bruce Broussard as Venture Partner
10/12
06:00 am
evh
Evolent Health, Inc. (NYSE: EVH) was upgraded by analysts at KeyCorp to a "strong-buy" rating.
Low
Report
Evolent Health, Inc. (NYSE: EVH) was upgraded by analysts at KeyCorp to a "strong-buy" rating.
10/11
08:07 am
evh
Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $35.00 price target on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $35.00 price target on the stock.
10/11
08:00 am
evh
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Low
Report
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
10/8
10:31 am
evh
Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $42.00 price target on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $42.00 price target on the stock.